Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000914475-25-000158
Filing Date
2025-07-30
Accepted
2025-07-30 16:04:04
Documents
67
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nbix-20250630.htm   iXBRL 10-Q 1184344
2 EX-31.1 q2-2025xexhibit311.htm EX-31.1 10245
3 EX-31.2 q2-2025xexhibit312.htm EX-31.2 10257
4 EX-32 q2-2025xexhibit32.htm EX-32 9859
10 GRAPHIC nbix-20250630_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-25-000158.txt   6107650

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20250630.xsd EX-101.SCH 39069
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbix-20250630_cal.xml EX-101.CAL 75165
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbix-20250630_def.xml EX-101.DEF 163239
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20250630_lab.xml EX-101.LAB 556425
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20250630_pre.xml EX-101.PRE 354882
70 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20250630_htm.xml XML 758171
Mailing Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22705 | Film No.: 251166936
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)